vs
Apellis Pharmaceuticals, Inc.（APLS）与Xperi Inc.（XPER）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是Xperi Inc.的1.7倍（$199.9M vs $116.5M），Xperi Inc.净利率更高（-14.7% vs -29.5%，领先14.8%），Xperi Inc.同比增速更快（-4.8% vs -5.9%），Xperi Inc.自由现金流更多（$1.2M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -1.0%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Xperi是一家美国跨国科技企业，总部位于加利福尼亚州圣何塞，专注研发消费电子与联网车载软件，以及宽带视频服务媒体平台，业务分为付费电视、消费电子、联网汽车与媒体平台四大板块，旗下拥有DTS、HD Radio、TiVo等知名品牌。
APLS vs XPER — 直观对比
营收规模更大
APLS
是对方的1.7倍
$116.5M
营收增速更快
XPER
高出1.2%
-5.9%
净利率更高
XPER
高出14.8%
-29.5%
自由现金流更多
XPER
多$15.4M
$-14.3M
两年增速更快
APLS
近两年复合增速
-1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $116.5M |
| 净利润 | $-59.0M | $-17.1M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | -12.7% |
| 净利率 | -29.5% | -14.7% |
| 营收同比 | -5.9% | -4.8% |
| 净利润同比 | -62.2% | -137.0% |
| 每股收益（稀释后） | $-0.40 | $-0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSXPER
| Q4 25 | $199.9M | $116.5M | ||
| Q3 25 | $458.6M | $111.6M | ||
| Q2 25 | $178.5M | $105.9M | ||
| Q1 25 | $166.8M | $114.0M | ||
| Q4 24 | $212.5M | $122.4M | ||
| Q3 24 | $196.8M | $132.9M | ||
| Q2 24 | $199.7M | $119.6M | ||
| Q1 24 | $172.3M | $118.8M |
净利润APLSXPER
| Q4 25 | $-59.0M | $-17.1M | ||
| Q3 25 | $215.7M | $-6.1M | ||
| Q2 25 | $-42.2M | $-14.8M | ||
| Q1 25 | $-92.2M | $-18.4M | ||
| Q4 24 | $-36.4M | $46.2M | ||
| Q3 24 | $-57.4M | $-16.8M | ||
| Q2 24 | $-37.7M | $-30.3M | ||
| Q1 24 | $-66.4M | $-13.1M |
营业利润率APLSXPER
| Q4 25 | -25.6% | -12.7% | ||
| Q3 25 | 48.7% | -1.2% | ||
| Q2 25 | -18.6% | -10.5% | ||
| Q1 25 | -50.0% | -14.4% | ||
| Q4 24 | -12.3% | -11.7% | ||
| Q3 24 | -24.0% | -14.0% | ||
| Q2 24 | -14.7% | -18.3% | ||
| Q1 24 | -36.0% | -27.2% |
净利率APLSXPER
| Q4 25 | -29.5% | -14.7% | ||
| Q3 25 | 47.0% | -5.5% | ||
| Q2 25 | -23.6% | -14.0% | ||
| Q1 25 | -55.3% | -16.1% | ||
| Q4 24 | -17.1% | 37.8% | ||
| Q3 24 | -29.2% | -12.6% | ||
| Q2 24 | -18.9% | -25.3% | ||
| Q1 24 | -38.5% | -11.0% |
每股收益（稀释后）APLSXPER
| Q4 25 | $-0.40 | $-0.37 | ||
| Q3 25 | $1.67 | $-0.13 | ||
| Q2 25 | $-0.33 | $-0.32 | ||
| Q1 25 | $-0.74 | $-0.41 | ||
| Q4 24 | $-0.30 | $1.02 | ||
| Q3 24 | $-0.46 | $-0.37 | ||
| Q2 24 | $-0.30 | $-0.67 | ||
| Q1 24 | $-0.54 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $96.8M |
| 总债务越低越好 | — | $27.7M |
| 股东权益账面价值 | $370.1M | $414.1M |
| 总资产 | $1.1B | $615.8M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资APLSXPER
| Q4 25 | $466.2M | $96.8M | ||
| Q3 25 | $479.2M | $96.8M | ||
| Q2 25 | $370.0M | $95.1M | ||
| Q1 25 | $358.4M | $88.0M | ||
| Q4 24 | $411.3M | $130.6M | ||
| Q3 24 | $396.9M | $72.7M | ||
| Q2 24 | $360.1M | $92.5M | ||
| Q1 24 | $325.9M | $95.2M |
总债务APLSXPER
| Q4 25 | — | $27.7M | ||
| Q3 25 | — | $27.7M | ||
| Q2 25 | — | $27.7M | ||
| Q1 25 | — | $27.7M | ||
| Q4 24 | — | $27.7M | ||
| Q3 24 | — | $27.7M | ||
| Q2 24 | — | $27.7M | ||
| Q1 24 | $93.1M | $27.7M |
股东权益APLSXPER
| Q4 25 | $370.1M | $414.1M | ||
| Q3 25 | $401.2M | $421.0M | ||
| Q2 25 | $156.3M | $419.8M | ||
| Q1 25 | $164.2M | $418.9M | ||
| Q4 24 | $228.5M | $429.1M | ||
| Q3 24 | $237.1M | $377.4M | ||
| Q2 24 | $264.3M | $388.7M | ||
| Q1 24 | $266.7M | $399.1M |
总资产APLSXPER
| Q4 25 | $1.1B | $615.8M | ||
| Q3 25 | $1.1B | $628.8M | ||
| Q2 25 | $821.4M | $629.2M | ||
| Q1 25 | $807.3M | $633.5M | ||
| Q4 24 | $885.1M | $667.8M | ||
| Q3 24 | $901.9M | $616.2M | ||
| Q2 24 | $904.5M | $619.2M | ||
| Q1 24 | $831.9M | $630.4M |
负债/权益比APLSXPER
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.06× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | 0.35× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $4.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $1.2M |
| 自由现金流率自由现金流/营收 | -7.1% | 1.0% |
| 资本支出强度资本支出/营收 | 0.1% | 2.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-5.9M |
8季度趋势，按日历期对齐
经营现金流APLSXPER
| Q4 25 | $-14.2M | $4.1M | ||
| Q3 25 | $108.5M | $7.5M | ||
| Q2 25 | $4.4M | $10.1M | ||
| Q1 25 | $-53.4M | $-22.3M | ||
| Q4 24 | $19.4M | $1.2M | ||
| Q3 24 | $34.1M | $-4.6M | ||
| Q2 24 | $-8.3M | $-2.1M | ||
| Q1 24 | $-133.0M | $-49.8M |
自由现金流APLSXPER
| Q4 25 | $-14.3M | $1.2M | ||
| Q3 25 | $108.3M | $6.7M | ||
| Q2 25 | $4.4M | $9.5M | ||
| Q1 25 | $-53.4M | $-23.3M | ||
| Q4 24 | $19.3M | $-510.0K | ||
| Q3 24 | — | $-5.6M | ||
| Q2 24 | $-8.4M | $-2.6M | ||
| Q1 24 | $-133.3M | $-51.6M |
自由现金流率APLSXPER
| Q4 25 | -7.1% | 1.0% | ||
| Q3 25 | 23.6% | 6.0% | ||
| Q2 25 | 2.5% | 9.0% | ||
| Q1 25 | -32.0% | -20.5% | ||
| Q4 24 | 9.1% | -0.4% | ||
| Q3 24 | — | -4.2% | ||
| Q2 24 | -4.2% | -2.2% | ||
| Q1 24 | -77.3% | -43.4% |
资本支出强度APLSXPER
| Q4 25 | 0.1% | 2.5% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.2% | 1.6% |
现金转化率APLSXPER
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
XPER
| Pay TV | $56.2M | 48% |
| Connected Car | $31.3M | 27% |
| Consumer Electronics | $17.2M | 15% |
| Media Platform | $11.8M | 10% |
